Skip to content

PSX Pharmaceuticals

MACTER Macter International Limited

Latest results: FY2026 · Jun 2026

FY2026 revenue Rs 12.2 bn (+17.5%), profit Rs 679.4 mn (-12.5%).

Last close · 13 Nov 2026

Rs 262.54 ▲ 7.15 (+2.80%)

▼ 26.0% 1 year

15 Oct 22 Oct 28 Oct 3 Nov 11 Nov Jun Jul Aug Sep Oct Dec Feb May Jul Oct 2022 2023 2024 2025 2026
220.0052-week range365.00
Market cap
Rs 12.0 bn
P/E
17.7×
FY2026
Sector 12.6× · higher
P/B
2.87×
FY2026
Sector 3.11× · lower
Dividend yield
0.0%
FY2026
ROE
17.4%
FY2026
Sector 21.7% · lower
EPS
Rs 14.83
FY2026
Book value / share
Rs 91.45
FY2026

Fundamentals

MACTER at a glance

Revenue · FY2026

Rs 12.2 bn

▲ 17.5% year on year

Profit attributable to shareholders · FY2026

Rs 679.4 mn

▼ 12.5% year on year

EPS – basic (Rs) · FY2026

Rs 14.83

▼ 12.5% year on year

Dividend per share (Rs) · FY2026

Rs 0.00

▼ 100.0% year on year

Net margin · FY2026

5.5%

-2.0 pts year on year

Debt to equity · FY2026

29.0%

+0.7 pts year on year

Price performance

MACTER returns

Close Rs 262.54
13 Nov 2026

Period Return Rs
MTD +14.0% +7.1 pts vs KSE +32.21
3M −6.0% −4.8 pts vs KSE −16.85
6M −4.3% −10.5 pts vs KSE −11.65
YTD −20.9% −23.1 pts vs KSE −69.39
FYTD −4.2% −2.8 pts vs KSE −11.43
1Y −26.0% −36.7 pts vs KSE −92.19
Long term
3Y +204.9% +45.0% a year −9.8 pts vs KSE +176.44
5Y +121.2% +17.2% a year −167.6 pts vs KSE +143.87

Price return from the last close before each period; the fiscal year ends 30 June. Dividends are not included.

Macter International Limited in brief

Macter International Limited (MACTER) reported revenue of Rs 12.2 bn for FY2026 (Jul 2025 – Jun 2026), up 17.5% from FY2025.

Profit attributable to shareholders was Rs 679.4 mn (EPS Rs 14.83), down 12.5%, a net margin of 5.5%.

No cash dividend was declared for FY2026.

Net debt stood at Rs 1.1 bn.

Return on equity was 17.4%.

Over the last five years revenue grew at a compound 17.8% a year.

At Rs 262.54 (close on 13 Nov 2026) the shares trade at 17.7× earnings (FY2026) and 2.87× book value.

Scorecard vs Pharmaceuticals

14 companies
Growth
Above average
20.7%
Profitability
Below average
5.5%
Financial health
Weak
29.0%
Valuation
Below average
17.7×
Dividends
Below average
0.0%

Ratings place the company in its sector: growth (3-year revenue growth), profitability (net margin; return on equity for banks, insurers and finance companies), financial health (debt to equity, industrial companies), valuation (P/E at today's price) and dividends (yield at today's price). Five dots = top fifth. Rated within the sector when at least four companies report the figure, otherwise against all PSX companies of the same type (marked vs PSX). Information, not investment advice.

Corporate

MACTER announcements & payouts

All MACTER announcements →
22 Oct 2026 · 15:36
Result · First quarter to 30 Sep 2026
Profit after tax (consolidated)
Rs 95.9 mn
EPS
Rs 2.10 -34.8%
EPS a year earlier
Rs 3.22
22 Oct 2026 · 15:35
Result · First quarter to 30 Sep 2026
Profit after tax (unconsolidated)
Rs 99.1 mn
EPS
Rs 2.16 -32.9%
EPS a year earlier
Rs 3.22
23 Sep 2026 · 15:39
Result · Full year to 30 Jun 2026
Profit after tax (consolidated)
Rs 675.2 mn
EPS
Rs 14.83 -12.5%
EPS a year earlier
Rs 16.95
23 Sep 2026 · 15:36
Result · Full year to 30 Jun 2026 AGM 28 Oct
Profit after tax (unconsolidated)
Rs 698.3 mn
EPS
Rs 15.24 -10.1%
EPS a year earlier
Rs 16.95

Book closure 21 Oct – 28 Oct 2026

Financial highlights

MACTER financial results

MACTER annual financial highlights (Rs bn)
Rs bn FY2026 Jul 2025 – Jun 2026 FY2025 Jul 2024 – Jun 2025 FY2024 Jul 2023 – Jun 2024 FY2023 Jul 2022 – Jun 2023 FY2022 Jul 2021 – Jun 2022 FY2021 Jul 2020 – Jun 2021 FY2020 * Jul 2019 – Jun 2020 FY2019 * Jul 2018 – Jun 2019 FY2018 Jul 2017 – Jun 2018 FY2017 Jul 2016 – Jun 2017
Revenue 12.2 10.4 8.0 6.9 5.6 5.4 5.7 4.2 4.1 3.6
Gross profit 5.9 4.7 3.4 2.9 2.5 2.2 2.1 1.8 1.8 1.7
Operating profit 1.4 1.2 0.7 0.5 0.5 0.4 0.2 0.2 0.4 0.4
Profit after tax 0.7 0.8 0.4 0.3 0.3 0.2 (0.0) 0.0 0.2 0.3
Profit attributable to shareholders 0.7 0.8 0.4 0.4 0.3 0.2 (0.0) 0.1 0.2 0.3
EPS – basic (Rs) Rs 14.83 16.95 8.88 7.80 6.47 5.77 (0.73) 1.79 6.29 7.01
Dividend per share (Rs) Rs 0.00 3.80 2.25 1.08 3.21 3.90 0.00 0.90 3.25 0.00
Total assets 7.9 6.6 5.4 4.8 4.3 3.7 3.9 3.3 3.0 2.7
Total equity 4.2 3.6 3.0 2.7 2.4 1.2 1.1 1.2 1.2 1.1
Total debt 1.2 1.0 0.7 0.6 0.4 1.4 1.6 1.3 0.4 0.2
Net cash from operating activities 0.4 0.6 0.3 0.1 0.7 0.5 (0.1) 0.1 0.4 0.0
Capital expenditure (0.7) (0.9) (0.3) (0.4) (0.5) (0.3) (0.2) (0.2) (0.4) (0.2)
Free cash flow (operating cash flow − capex) (0.3) (0.3) 0.0 (0.4) 0.3 0.3 (0.3) (0.1) (0.0) (0.1)
MACTER quarterly financial highlights (Rs bn)
Rs bn TTM to Jun 2026 Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024
Revenue 12.2 2.9 2.9 3.5 2.9 2.7 2.5 2.9 2.3
Gross profit 5.9 1.4 1.4 1.8 1.3 1.2 1.2 1.4 1.0
Operating profit 1.4 0.3 0.2 0.6 0.3 0.4 0.2 0.5 0.2
Profit after tax 0.7 0.1 0.1 0.3 0.1 0.3 0.1 0.3 0.1
Profit attributable to shareholders 0.7 0.2 0.1 0.3 0.1 0.3 0.1 0.3 0.1
EPS – basic (Rs) Rs 14.83 3.33 2.01 6.27 3.22 6.31 2.00 6.69 1.95
Dividend per share (Rs) Rs 0.00 0.00 0.00 0.00 0.00 2.00 1.80 0.00 0.00
Total assets 7.9 7.9 7.8 7.4 6.9 6.6 6.8 6.5 5.5
Total equity 4.2 4.2 4.1 4.0 3.8 3.6 3.4 3.3 3.0
Total debt 1.2 1.2 1.3 1.0 0.9 1.0 1.1 0.8 0.7
Net cash from operating activities 0.4 0.3 (0.3) 0.1 0.2 0.5 (0.0) 0.1 0.1
Capital expenditure (0.7) (0.2) (0.2) (0.3) (0.1) (0.2) (0.3) (0.2) (0.1)
Free cash flow (operating cash flow − capex) (0.3) 0.1 (0.4) (0.1) 0.1 0.3 (0.3) (0.2) (0.0)

Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 17 Oct 2026.

MACTER charts

Revenue and profit Revenue Profit attributable
Revenue and profit Rs 12 bn -Rs 28 mn Revenue FY17: Rs 3.6 bn Profit attributable FY17: Rs 274.2 mn FY17 Revenue FY18: Rs 4.1 bn Profit attributable FY18: Rs 246.3 mn FY18 Revenue FY19: Rs 4.2 bn Profit attributable FY19: Rs 70.3 mn FY19 Revenue FY20: Rs 5.7 bn Profit attributable FY20: -Rs 28.4 mn FY20 Revenue FY21: Rs 5.4 bn Profit attributable FY21: Rs 226.0 mn FY21 Revenue FY22: Rs 5.6 bn Profit attributable FY22: Rs 291.8 mn FY22 Revenue FY23: Rs 6.9 bn Profit attributable FY23: Rs 357.1 mn FY23 Revenue FY24: Rs 8.0 bn Profit attributable FY24: Rs 406.7 mn FY24 Revenue FY25: Rs 10.4 bn Profit attributable FY25: Rs 776.4 mn FY25 Revenue FY26: Rs 12.2 bn Profit attributable FY26: Rs 679.4 mn FY26
Margins Gross margin Operating margin Net margin
Margins 53% 26% -1% Gross margin FY17: 46.1% Gross margin FY18: 45.0% Gross margin FY19: 42.7% Gross margin FY20: 37.3% Gross margin FY21: 41.4% Gross margin FY22: 45.2% Gross margin FY23: 42.0% Gross margin FY24: 42.9% Gross margin FY25: 45.6% Gross margin FY26: 48.6% Operating margin FY17: 11.4% Operating margin FY18: 9.6% Operating margin FY19: 4.3% Operating margin FY20: 4.2% Operating margin FY21: 8.1% Operating margin FY22: 8.7% Operating margin FY23: 7.6% Operating margin FY24: 8.6% Operating margin FY25: 11.8% Operating margin FY26: 11.2% Net margin FY17: 7.6% Net margin FY18: 6.1% Net margin FY19: 1.0% Net margin FY20: -0.8% Net margin FY21: 4.0% Net margin FY22: 5.1% Net margin FY23: 5.0% Net margin FY24: 5.0% Net margin FY25: 7.6% Net margin FY26: 5.5% FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26
Cash flow Operating cash flow Capex Free cash flow
Cash flow Rs 714 mn -Rs 872 mn Operating cash flow FY17: Rs 49.1 mn Capex FY17: -Rs 177.5 mn Free cash flow FY17: -Rs 128.4 mn FY17 Operating cash flow FY18: Rs 376.3 mn Capex FY18: -Rs 409.1 mn Free cash flow FY18: -Rs 32.8 mn FY18 Operating cash flow FY19: Rs 52.2 mn Capex FY19: -Rs 161.5 mn Free cash flow FY19: -Rs 109.4 mn FY19 Operating cash flow FY20: -Rs 118.0 mn Capex FY20: -Rs 158.8 mn Free cash flow FY20: -Rs 276.8 mn FY20 Operating cash flow FY21: Rs 543.0 mn Capex FY21: -Rs 260.9 mn Free cash flow FY21: Rs 282.1 mn FY21 Operating cash flow FY22: Rs 714.0 mn Capex FY22: -Rs 458.6 mn Free cash flow FY22: Rs 255.4 mn FY22 Operating cash flow FY23: Rs 75.9 mn Capex FY23: -Rs 439.2 mn Free cash flow FY23: -Rs 363.3 mn FY23 Operating cash flow FY24: Rs 331.2 mn Capex FY24: -Rs 306.0 mn Free cash flow FY24: Rs 25.2 mn FY24 Operating cash flow FY25: Rs 588.6 mn Capex FY25: -Rs 872.3 mn Free cash flow FY25: -Rs 283.6 mn FY25 Operating cash flow FY26: Rs 388.5 mn Capex FY26: -Rs 693.8 mn Free cash flow FY26: -Rs 305.3 mn FY26

Valuation

MACTER valuation at today's price

Price to earnings (P/E)
17.7×
EPS Rs 14.83 (FY2026)
Price to book (P/B)
2.87×
Book value Rs 91.45 (FY2026)
Dividend yield
0.0%
DPS Rs 0.00 (FY2026)
Earnings yield
5.6%
EPS ÷ price

At the closing price of Rs 262.54 on 13 Nov 2026. P/E and P/B are not shown when earnings or book value are negative.

Sector peers

MACTER vs Pharmaceuticals companies

Largest companies in the sector at today's prices
Company Market cap P/E P/B Yield ROE 3-yr growth
MACTER Rs 12.0 bn 17.7× 2.87× 0.0% 17.4% 20.7%
GLAXO Rs 107.1 bn 10.3× 3.11× 5.1% 32.4% 16.3%
ABOT Rs 97.9 bn 11.4× 3.05× 4.0% 28.8% 15.2%
HALEON Rs 81.6 bn 12.4× 5.02× 4.3% 47.6% 16.2%
HINOON Rs 50.8 bn 12.8× 3.95× 5.2% 32.3% 20.5%
AGP Rs 43.8 bn 11.7× 2.92× 5.1% 25.9% 26.0%
HPL Rs 38.5 bn 10.3× 4.50× 6.0% 38.6% 18.6%
FEROZ Rs 15.8 bn 16.1× 1.19× 1.5% 7.6% 27.9%
CPHL Rs 14.5 bn 18.3× 1.34× 0.0% 7.3% 4.3%

All Pharmaceuticals companies, medians and leaders →

Analyses & signals 0

Win rate — · 0 closed signals · average return —

No analyses published for MACTER yet.

MACTER: frequently asked questions

What is MACTER's EPS?

Macter International Limited reported basic earnings per share of Rs 14.83 for FY2026 (Jul 2025 – Jun 2026).

What is MACTER's P/E ratio?

At the closing price of Rs 262.54 on 13 Nov 2026, MACTER trades at a P/E of 17.7× based on EPS of Rs 14.83 (FY2026).

Does MACTER pay dividends?

Macter International Limited did not declare a cash dividend for FY2026.

What was MACTER's revenue and profit in FY2026?

Macter International Limited reported revenue of Rs 12.2 bn and profit attributable to shareholders of Rs 679.4 mn for FY2026 (Jul 2025 – Jun 2026).

What is MACTER's book value per share?

Macter International Limited's book value per share was Rs 91.45 at the end of FY2026. The shares trade at 2.87× book value.

How has MACTER's share price performed?

MACTER's share price is down 20.9% year to date (KSE-100: +2.2%), down 26.0% over one year (KSE-100: +10.7%) and up 121.2% over five years (KSE-100: +288.8%), as of 13 Nov 2026. These are price returns; dividends are not included.

Information only, not investment advice.